{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:00:36Z","timestamp":1777528836877,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T00:00:00Z","timestamp":1460419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s40265-016-0574-3","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T08:12:03Z","timestamp":1460621523000},"page":"805-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Idebenone: A Review in Leber\u2019s Hereditary Optic Neuropathy"],"prefix":"10.1007","volume":"76","author":[{"given":"Katherine A.","family":"Lyseng-Williamson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"issue":"4","key":"574_CR1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","volume":"55","author":"JA Fraser","year":"2010","unstructured":"Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol. 2010;55(4):299\u2013334.","journal-title":"Surv Ophthalmol."},{"issue":"5","key":"574_CR2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/eye.2014.37","volume":"28","author":"P Yu-Wai-Man","year":"2014","unstructured":"Yu-Wai-Man P, Votruba M, Moore AT, et al. Treatment strategies for inherited optic neuropathies: past, present and future. Eye. 2014;28(5):521\u20137.","journal-title":"Eye."},{"issue":"5","key":"574_CR3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ana.20236","volume":"56","author":"ML Valentino","year":"2004","unstructured":"Valentino ML, Barboni P, Ghelli A, et al. The ND1 gene of complex I is a mutational hot spot for Leber\u2019s hereditary optic neuropathy. Ann Neurol. 2004;56(5):631\u201341.","journal-title":"Ann Neurol."},{"issue":"Pt 1","key":"574_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/brain\/124.1.209","volume":"124","author":"PF Chinnery","year":"2001","unstructured":"Chinnery PF, Brown DT, Andrews RM, et al. The mitochondrial ND6 gene is a hot spot for mutations that cause Leber\u2019s hereditary optic neuropathy. Brain. 2001;124(Pt 1):209\u201318.","journal-title":"Brain."},{"issue":"8","key":"574_CR5","doi-asserted-by":"crossref","first-page":"e42242","DOI":"10.1371\/journal.pone.0042242","volume":"7","author":"A Achilli","year":"2012","unstructured":"Achilli A, Iommarini L, Olivieri A, et al. Rare primary mitochondrial DNA mutations and probable synergistic variants in Leber\u2019s hereditary optic neuropathy. PLoS One. 2012;7(8):e42242.","journal-title":"PLoS One."},{"issue":"10","key":"574_CR6","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0042-6989(97)00444-6","volume":"38","author":"N Howell","year":"1998","unstructured":"Howell N. Leber hereditary optic neuropathy: respiratory chain dysfunction and degeneration of the optic nerve. Vis Res. 1998;38(10):1495\u2013504.","journal-title":"Vis Res."},{"key":"574_CR7","first-page":"001","volume":"S1","author":"N Gueven","year":"2014","unstructured":"Gueven N. Optic neurodegeneration: time to act. Biol Med. 2014;S1:001. doi: 10.4172\/0974-8369.S1-001 .","journal-title":"Biol Med."},{"issue":"7","key":"574_CR8","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1167\/iovs.08-3166","volume":"50","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Korsten A, Leonhardt M, et al. Quality of life in patients with Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2009;50(7):3112\u20135.","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"12","key":"574_CR9","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1167\/iovs.06-0520","volume":"47","author":"P Barboni","year":"2006","unstructured":"Barboni P, Savini G, Valentino ML, et al. Leber\u2019s hereditary optic neuropathy with childhood onset. Invest Ophthalmol Vis Sci. 2006;47(12):5303\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"574_CR10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13023-014-0158-9","volume":"9","author":"K Dimitriadis","year":"2014","unstructured":"Dimitriadis K, Leonhardt M, Yu-Wai-Man P, et al. Leber\u2019s hereditary optic neuropathy with late disease onset: clinical and molecular characteristics of 20 patients. Orphanet J Rare Dis. 2014;9:158.","journal-title":"Orphanet J Rare Dis."},{"issue":"Pt 2","key":"574_CR11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/brain\/awt343","volume":"137","author":"C Giordano","year":"2014","unstructured":"Giordano C, Iommarini L, Giordano L, et al. Efficient mitochondrial biogenesis drives incomplete penetrance in Leber\u2019s hereditary optic neuropathy. Brain. 2014;137(Pt 2):335\u201353.","journal-title":"Brain."},{"issue":"Pt 9","key":"574_CR12","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/brain\/awp158","volume":"132","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Yu-Wai-Man P, Korsten A, et al. Gene-environment factors in Leber hereditary optic neuropathy. Brain. 2009;132(Pt 9):2317\u201326.","journal-title":"Brain."},{"key":"574_CR13","doi-asserted-by":"crossref","first-page":"e2021","DOI":"10.1038\/cddis.2015.364","volume":"6","author":"L Giordano","year":"2015","unstructured":"Giordano L, Deceglie S, d\u2019Adamo P, et al. Cigarette toxicity triggers Leber\u2019s hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways. Cell Death Dis. 2015;6:e2021.","journal-title":"Cell Death Dis."},{"key":"574_CR14","first-page":"e2021","volume":"6","author":"V Carelli","year":"2015","unstructured":"Carelli V, d\u2019Adamo P, Valentino ML, et al. Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion. Brain. 2015;6:e2021.","journal-title":"Brain."},{"issue":"10","key":"574_CR15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00417-006-0269-7","volume":"244Z","author":"JW Pott","year":"2006","unstructured":"Pott JW, Wong KH. Leber\u2019s hereditary optic neuropathy and vitamin B12 deficiency. Graefes Arch Clin Exp Ophthalmol. 2006;244Z(10):1357\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"issue":"1","key":"574_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/13816810701867607","volume":"29","author":"SP Shankar","year":"2008","unstructured":"Shankar SP, Fingert JH, Carelli V, et al. Evidence for a novel X-linked modifier locus for Leber hereditary optic neuropathy. Ophthalmic Genet. 2008;29(1):17\u201324.","journal-title":"Ophthalmic Genet."},{"issue":"Pt 1","key":"574_CR17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/brain\/awq276","volume":"134","author":"C Giordano","year":"2011","unstructured":"Giordano C, Montopoli M, Perli E, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber\u2019s hereditary optic neuropathy. Brain. 2011;134(Pt 1):220\u201334.","journal-title":"Brain."},{"issue":"4","key":"574_CR18","doi-asserted-by":"crossref","first-page":"e36153","DOI":"10.1371\/journal.pone.0036153","volume":"7","author":"M Erb","year":"2012","unstructured":"Erb M, Hoffmann-Enger B, Deppe H, et al. Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I. PLoS One. 2012;7(4):e36153.","journal-title":"PLoS One."},{"issue":"3","key":"574_CR19","doi-asserted-by":"crossref","first-page":"e17963","DOI":"10.1371\/journal.pone.0017963","volume":"6","author":"RH Haefeli","year":"2011","unstructured":"Haefeli RH, Erb M, Gemperli AC, et al. NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels. PLoS One. 2011;6(3):e17963.","journal-title":"PLoS One."},{"issue":"1","key":"574_CR20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1021\/tx970136j","volume":"11","author":"A Mordente","year":"1998","unstructured":"Mordente A, Martorana G, Minotti G, et al. Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1, 4-benzoquinone (idebenone). Chem Res Toxicol. 1998;11(1):54\u201363.","journal-title":"Chem Res Toxicol."},{"issue":"2","key":"574_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-510X(98)00239-1","volume":"160","author":"V Carelli","year":"1998","unstructured":"Carelli V, Barboni P, Zacchini A, et al. Leber\u2019s hereditary optic neuropathy (LHON) with 14484\/ND6 mutation in a North African patient. J Neurol Sci. 1998;160(2):183\u20138.","journal-title":"J Neurol Sci."},{"issue":"6","key":"574_CR22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4321\/S0365-66912007000600012","volume":"82","author":"N Barnils","year":"2007","unstructured":"Barnils N, Mesa E, Mu\u00f1oz S, et al. Response to idebenone and multivitamin therapy in Leber\u2019s hereditary optic neuropathy. Arch Soc Esp Oftalmol. 2007;82(6):377\u201380.","journal-title":"Arch Soc Esp Oftalmol."},{"issue":"6","key":"574_CR23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jnnp.71.6.813","volume":"71","author":"V Carelli","year":"2001","unstructured":"Carelli V, Valentino ML, Liguori R, et al. Leber\u2019s hereditary optic neuropathy (LHON\/11778) with myoclonus: report of two cases. J Neurol Neurosurg Psychiatry. 2001;71(6):813\u20136.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"574_CR24","doi-asserted-by":"crossref","unstructured":"Orssaud C, Robert M, Roche O, et al. Visual function improvement after idebenone therapy in Leber hereditary optic neuropathy [abstract no. T137]. Acta Ophthalmol (Copenh). 2012;90(Suppl s249).","DOI":"10.1111\/j.1755-3768.2012.T137.x"},{"key":"574_CR25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(96)00311-5","volume":"148","author":"P Cortelli","year":"1997","unstructured":"Cortelli P, Montagna P, Pierangeli G. Clinical and brain bioenergetics improvement with idebenone in a patient with Leber\u2019s hereditary optic neuropathy: a clinical and 31P-MRS study. J Neurol Sci. 1997;148:25\u201331.","journal-title":"J Neurol Sci."},{"issue":"8815","key":"574_CR26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0140-6736(92)91442-B","volume":"340","author":"Y Mashima","year":"1992","unstructured":"Mashima Y, Hiida Y, Oguchi Y. Remission of Leber\u2019s hereditary optic neuropathy with idebenone. Lancet. 1992;340(8815):368\u20139.","journal-title":"Lancet."},{"issue":"3","key":"574_CR27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00041327-200020030-00006","volume":"20","author":"Y Mashima","year":"2000","unstructured":"Mashima Y, Kigasawa K, Wakakura M, et al. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J Neuroophthalmol. 2000;20(3):166\u201370.","journal-title":"J Neuroophthalmol."},{"issue":"Suppl 2","key":"574_CR28","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/S0924-977X(11)70228-0","volume":"21","author":"J Jancic","year":"2011","unstructured":"Jancic J. Effectiveness of idebenone therapy in Leber\u2019s hereditary optic neuropathy [abstract no. P.8.006]. Eur Neuropsychopharmacol. 2011;21(Suppl 2):S175.","journal-title":"Eur Neuropsychopharmacol."},{"issue":"Suppl 4","key":"574_CR29","first-page":"A4","volume":"50","author":"V Carelli","year":"1998","unstructured":"Carelli V, Ghelli A, Cevoli S, et al. Idebenone therapy in Leber\u2019s hereditary optic neuropathy: report of six cases [abstract]. Neurology. 1998;50(Suppl 4):A4.","journal-title":"Neurology."},{"issue":"13","key":"574_CR30","first-page":"1440","volume":"50","author":"JG Eng","year":"2009","unstructured":"Eng JG, Aggarwal D, Sadun AA. Idebenone treatment in patients with Leber hereditary optic neuropathy [abstract]. Invest Ophthalmol Vis Sci. 2009;50(13):1440.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"574_CR31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2015.01.009","volume":"4","author":"N Gueven","year":"2015","unstructured":"Gueven N, Woolley K, Smith J. Border between natural product and drug: comparison of the related benzoquinones idebenone and coenzyme Q10. Redox Biol. 2015;4:289\u201395.","journal-title":"Redox Biol."},{"key":"574_CR32","unstructured":"Raxone (idebenone): assessment report (EMA\/480039\/2015). London: European Medicines Agency; 2015."},{"issue":"2","key":"574_CR33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbabio.2011.10.012","volume":"1817","author":"V Giorgio","year":"2012","unstructured":"Giorgio V, Petronilli V, Gheli A, et al. The effects of idebenone on mitochondrial bioenergetics. Biochim Biophys Acta. 2012;1817(2):363\u20139.","journal-title":"Biochim Biophys Acta."},{"key":"574_CR34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/1756-0500-4-557","volume":"4","author":"C Angebault","year":"2011","unstructured":"Angebault C, Gueguen N, Desquiret-Dumas V, et al. Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration. BMC Res Notes. 2011;4:557.","journal-title":"BMC Res Notes."},{"issue":"9","key":"574_CR35","doi-asserted-by":"crossref","first-page":"e45182","DOI":"10.1371\/journal.pone.0045182","volume":"7","author":"FD Heitz","year":"2012","unstructured":"Heitz FD, Erb M, Anklin C, et al. Idebenone protects against retinal damage and loss of vision in a mouse model of Leber\u2019s hereditary optic neuropathy. PLoS One. 2012;7(9):e45182.","journal-title":"PLoS One."},{"issue":"5","key":"574_CR36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00228-008-0596-1","volume":"65","author":"M Bodmer","year":"2009","unstructured":"Bodmer M, Vankan P, Dreier M, et al. Pharmacokinetics and metabolism of idebenone in healthy male subjects. Eur J Clin Pharmacol. 2009;65(5):493\u2013501.","journal-title":"Eur J Clin Pharmacol."},{"issue":"Suppl 1","key":"574_CR37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00415-009-1006-z","volume":"256","author":"K Kutz","year":"2009","unstructured":"Kutz K, Drewe J, Vankan P. Pharmacokinetic properties and metabolism of idebenone. J Neurol. 2009;256(Suppl 1):31\u20135.","journal-title":"J Neurol."},{"key":"574_CR38","unstructured":"Raxone (idebenone) 150\u00a0mg film-coated tablets: summary of product characteristics. London: European Medicines Agency; 2015."},{"issue":"9","key":"574_CR39","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","volume":"134","author":"T Klopstock","year":"2011","unstructured":"Klopstock T, Yu-Wai-Man P, Dimitriadis K, et al. A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy. Brain. 2011;134(9):2677\u201386.","journal-title":"Brain."},{"issue":"Suppl 1","key":"574_CR40","first-page":"7","volume":"37","author":"T Klopstock","year":"2013","unstructured":"Klopstock T, Metz G, Yu-Wai-Man P, et al. Early start of treatment favours beneficial effect of idebenone in leber hereditary optic neuropathy [abstract]. Neuroophthalmology. 2013;37(Suppl 1):7.","journal-title":"Neuroophthalmology."},{"issue":"1","key":"574_CR41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/WNO.0b013e318272c643","volume":"33","author":"G Rudolph","year":"2013","unstructured":"Rudolph G, Dimitriadis K, B\u00fcchner B, et al. Effects of idebenone on color vision in patients with Leber hereditary optic neuropathy. J Neuroophthalmol. 2013;33(1):30\u20136.","journal-title":"J Neuroophthalmol."},{"issue":"2","key":"574_CR42","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1093\/brain\/aws279","volume":"136","author":"T Klopstock","year":"2013","unstructured":"Klopstock T, Metz G, Yu-Wai-Man P, et al. Persistence of the treatment effect of idebenone in Leber\u2019s hereditary optic neuropathy. Brain. 2013;136(2):e230.","journal-title":"Brain."},{"key":"574_CR43","doi-asserted-by":"crossref","unstructured":"Metz G, Klopstock T, Gallenm\u00fcller C, et al. Clinical experience with idebenone (Raxone\u00ae) in the treatment of patients with Leber\u2019s hereditary optic neuropathy (LHON) [abstract no. 0429 plus poster]. Acta Ophthalmol (Copenh). 2015;93(Suppl s255).","DOI":"10.1111\/j.1755-3768.2015.0429"},{"key":"574_CR44","doi-asserted-by":"crossref","unstructured":"Metz G, Coppard N, Petraki D, et al. A case report survey (CRS) on the natural history of visual acuity in patients with Leber\u2019s hereditary optic neuropathy (LHON) [abstract no. T110 plus poster]. Acta Ophthalmol (Copenh). 2014;92(Suppl s253).","DOI":"10.1111\/j.1755-3768.2014.T110.x"},{"issue":"5","key":"574_CR45","doi-asserted-by":"crossref","first-page":"451","DOI":"10.12809\/hkmj134085","volume":"20","author":"SW Cheng","year":"2014","unstructured":"Cheng SW, Ko CH, Yau SK, et al. Novel use of idebenone in Leber\u2019s hereditary optic neuropathy in Hong Kong. Hong Kong Med J. 2014;20(5):451\u20134.","journal-title":"Hong Kong Med J."},{"issue":"1","key":"574_CR46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/WNO.0b013e318241da45","volume":"32","author":"EJ Sabet-Peyman","year":"2012","unstructured":"Sabet-Peyman EJ, Khaderi KR, Sadun AA. Is Leber hereditary optic neuropathy treatable? Encouraging results with idebenone in both prospective and retrospective trials and an illustrative case. J Neuroophthalmol. 2012;32(1):54\u20137.","journal-title":"J Neuroophthalmol."},{"issue":"12","key":"574_CR47","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1007\/s00415-015-7955-5","volume":"262","author":"M Eckenweiler","year":"2015","unstructured":"Eckenweiler M, Catarino CB, Gallenmueller C, et al. Mitochondrial DNA mutation 14487T>C manifesting as Leber\u2019s hereditary optic neuropathy. J Neurol. 2015;262(12):2776\u20139.","journal-title":"J Neurol."},{"issue":"9","key":"574_CR48","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1093\/brain\/awr180","volume":"134","author":"V Carelli","year":"2011","unstructured":"Carelli V, La Morgia C, Valentino ML, et al. Idebenone treatment in Leber\u2019s hereditary optic neuropathy. Brain. 2011;134(9):e188.","journal-title":"Brain."},{"issue":"1","key":"574_CR49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11940-010-0100-y","volume":"13","author":"AA Sadun","year":"2011","unstructured":"Sadun AA, La Morgia C, Carelli V. Leber\u2019s hereditary optic neuropathy. Curr Treat Options Neurol. 2011;13(1):109\u201317.","journal-title":"Curr Treat Options Neurol."}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-016-0574-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-016-0574-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-016-0574-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:13:18Z","timestamp":1567789998000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-016-0574-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1007\/s40265-016-0574-3","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,12]]}}}